Skip to content
Winfred
Sign up
Back to Investors
J&

Johnson & Johnson Development Corporation

Corporate
Follow

Portfolio

1

companies

By category

  • BioTech£4.0M

By location

  • Cambridge£4.0M

Portfolio companies

I

Inivata

Inivata develops blood tests using circulating tumour DNA to improve cancer care.

Recent investments

£4.0M

Inivata raises up to £4m from Imperial Innovations, Cambridge Innovation Capital and Johnson & Johnson Development Corporation to advance cancer blood tests.

BioTechHealthTech

The funding was provided by Imperial Innovations, Cambridge Innovation Capital and Johnson & Johnson Development Corporation.

"This investment will secure the development of this technology in Cambridge and facilitate its translation into the clinic for the benefit of patients"
— Robert Tansley
I
Inivata— Cambridge, UK Follow
II
Cambridge Innovation Capital
J&
Imperial Innovations + 2 others